NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with a market capitalization of $17.4 billion, has announced results from its Phase 3 TALAPRO-2 study which show that a combination of ...

(THE CONVERSATION) As research into psychedelics and their medical uses makes a comeback, scientists are having to deal with the legacy – both scientific and social – of a 40-year nearly total freeze ...

Numbers released by the Heart Failure Society of America in September 2024 reveal that approximately 6.7 million Americans ...

"Since we are talking about an exchange, yesterday we said after the telephone conversation that the President of the United States confirmed that all agreements from the American side will be ...

It’s obvious these drugs are trimming waistlines across the nation; what may be less obvious is that they might also reshape ...

This oligarchy/plutocracy constitutes 0.1% of the American population. It owns 14% of the nation’s wealth, $22 trillion in ...

NEW YORK - Pfizer Inc. (NYSE: NYSE:PFE), a pharmaceutical giant with $63.6 billion in annual revenue and an impressive 74% gross profit margin, has announced the U.S. Food and Drug Administration's ...

Ketamine also has come under increasing scrutiny as a treatment recently, with studies suggesting that for some patients it ...

The tragic early death of "Friends" star Matthew Perry from a ketamine overdose in 2023 has swung a spotlight on th ...

The anesthetic ketamine is being hailed as a breakthrough therapy for people with post-traumatic stress disorder (PTSD), treatment-resistant depression and other mood disorders.

Data on enfortumab vedotin plus pembrolizumab for advanced bladder cancer, along with updates on antibody-drug conjugates, ...

The American Society of Anesthesiologists has issued new guidance on ketamine administration for patients suffering from post-traumatic stress disorder, treatment-resistant depression and other mood ...